A slide from a presentation titled "Opana ER - State Substitution Law Impact on Share". The main content of the page is a table labeled "Share by State Substitution Law Category Jan - May 2013". The slide has the Purdue logo in the upper right corner.
The columns of the table are labeled "State Approach" "OpanaER" "Global/Impax (non-AB Rated Jan 2013 launch)" and "Actavist (AB Rated 2011 launch)".
The rows in the State approaches column are "Negative State Formulary" "Orange Book + can substitute non rated drugs" "Orange Book + Permits Subst in same therapeutic class" "Orange Book + positive formulary" "Positive state formulary" "Professional Judgement State" "Pure Orange Book" and "Total".
The values in the Opana ER column range from 79.6% - 90.2%. The values in the Global/Impax column range from 5.2%-12.1%. The values in the Actavis column range from 3.2%-12.5%.
Category
Source 1 of 15
-
Date
2018
Collection
-
Date
2018
Collection
-
Date
2018
Collection
-
Date
2018
Collection
-
Date
2018
Collection
-
Date
2018
Collection
-
Date
2018
Collection
-
Date
2018
Collection
-
Date
2018
Collection
-
Date
2019
Collection
-
Date
2018
Collection
-
Date
2018
Collection
-
Date
2018
Collection
-
Date
2019
Collection
-
Date
2018
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.